Status:
UNKNOWN
Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis.
Lead Sponsor:
University College, London
Conditions:
Prostate Cancer
Prostate Neoplasm
Eligibility:
MALE
18-90 years
Brief Summary
Multiparametric magnetic resonance imaging (mpMRI) is now widely used to risk stratify men with a suspicion of prostate cancer and identify suspicious regions for biopsy. Advanced MRI techniques have ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Men aged 18-90 with a clinical suspicion of prostate cancer
- No contraindication to MRI
- Exclusion Criteria
- Men unable to have a MRI scan, or in whom artefact would reduce quality of MRI
- Men unable to given informed consent
- Previous treatment (prostatectomy, radiotherapy, brachytherapy) of prostate cancer
- Ongoing hormonal treatment for prostate cancer
Exclusion
Key Trial Info
Start Date :
October 23 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04792138
Start Date
October 23 2020
End Date
October 1 2023
Last Update
March 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University College London Hospital
London, United Kingdom